These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6701959)

  • 21. Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies.
    Arnold ML; Ntokou IS; Doxiadis II; Spriewald BM; Boletis JN; Iniotaki AG
    Transpl Int; 2014 Mar; 27(3):253-61. PubMed ID: 24118579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2.
    Bredius RG; de Vries CE; Troelstra A; van Alphen L; Weening RS; van de Winkel JG; Out TA
    J Immunol; 1993 Aug; 151(3):1463-72. PubMed ID: 8335940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b.
    Amir J; Scott MG; Nahm MH; Granoff DM
    J Infect Dis; 1990 Jul; 162(1):163-71. PubMed ID: 2355193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic properties of transplantation immune sera. IV. Influence of the course of immunization, dilution and complexing to antigen on enhancing activity of Ig classes.
    Duc HT; Kinsky RG; Kanellopoulos J; Voisin GA
    J Immunol; 1975 Oct; 115(4):1143-50. PubMed ID: 1176768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.
    Lems SP; Jacobs CW; Capel PJ; Koene RA
    J Immunol; 1987 Apr; 138(7):2082-7. PubMed ID: 3549896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged skin allograft survival through enhancement effects on donor tissue.
    Deutsch HL; Edington HD; McCullough CM; Sugarbaker PH
    Transplantation; 1986 Aug; 42(2):200-4. PubMed ID: 3526658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
    J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo.
    Auchincloss H; Ghobrial RR; Russell PS; Winn HJ
    Transplantation; 1988 Jun; 45(6):1118-23. PubMed ID: 3289152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-reactive lymphocytes are opsonized in mice with passively enhanced skin allografts but not in tolerant mice.
    Hutchinson IV; Rayfield LS; Brent L
    Transplantation; 1982 Feb; 33(2):204-6. PubMed ID: 7036475
    [No Abstract]   [Full Text] [Related]  

  • 30. A preparation of Fc fragment of normal mouse IgG1 for production of rabbit anti mouse IgG1 serum.
    Harris TN; Harris S; Henri EM
    J Immunol Methods; 1975 Sep; 8(3):203-12. PubMed ID: 810516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of graft-versus-host disease using antibody to Thy 1. A role for complement in vivo.
    Hamilton BL; Harris D
    Transplantation; 1985 Jul; 40(1):90-6. PubMed ID: 2861676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-associated differences in the immune response against fetal major histocompatibility antigens. II. Association of the female IgG1 with H-2K-encoded alloantigens.
    Tartakovsky B; de Baetselier P; Feldman M; Segal S
    Transplantation; 1983 Aug; 36(2):191-7. PubMed ID: 6192571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen-reactive cell opsonization (ARCO) and its role in antibody-mediated immune suppression.
    Hutchinson IV
    Immunol Rev; 1980; 49():167-97. PubMed ID: 6154641
    [No Abstract]   [Full Text] [Related]  

  • 36. Determinant analysis and interaction studies on monoclonal antibodies to bovine IgG1 and IgG2.
    Kar SK; Nayak AR; Joshi B; Singh V
    Indian J Biochem Biophys; 1992 Feb; 29(1):25-30. PubMed ID: 1375582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of decomplementation with cobra venom factor on the passive immunological enhancement of mouse skin allografts.
    Hutchinson IV; Brent L
    Transplantation; 1982 Jul; 34(1):64-7. PubMed ID: 6750879
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structural and functional characteristics of IgG1- and IgG2-antibody subclasses in the guinea pig. 2. Production and testing of specific antisera against IgG1 and IgG2-antibody subclasses and against Fc-, Fc'- and Fab-papain fragments of IgG2-antibodies in guinea pigs].
    Drössler K; Hädge D; Ambrosius H
    Acta Biol Med Ger; 1982; 41(4):393-400. PubMed ID: 7124257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.